匈牙利政府藥品監(jiān)管機構(gòu)1月29日批準使用中國國藥集團研發(fā)的新冠疫苗，該國成為首個批準使用中國疫苗的歐盟成員國。匈牙利總理歐爾班表示，他最相信中國生產(chǎn)的新冠疫苗，個人會選擇中國疫苗。

Hungary became the European Union’s first member to approve China’s Sinopharm COVID-19 vaccine, sealing a deal on Friday for 5 million doses just a week after becoming the first EU member to buy Russia’s Sputnik V vaccine.

匈牙利成為首個批準使用中國國藥集團新冠疫苗的歐盟成員國，并在1月29日與中方簽訂了購買500萬劑疫苗的正式合同。就在一周前，匈牙利成為首個購買俄羅斯“衛(wèi)星V”新冠疫苗的歐盟成員國。

Foreign Minister Peter Szijjarto said the Sinopharm vaccines were enough to inoculate 2.5 million people, or about a quarter of its population, delivered in four batches over four months.

匈牙利外交部長彼得·西亞爾托說，中國國藥集團研發(fā)的新冠疫苗將分4批在4個月內(nèi)交付匈牙利，足夠250萬人接種，大約相當于匈牙利全國人口的四分之一。

Prime Minister Viktor Orban said he would personally opt to receive the Chinese vaccine, as he trusted it more than others.

匈牙利總理歐爾班表示，他最相信中國生產(chǎn)的新冠疫苗，個人會選擇中國疫苗。

“I’m waiting for the Chinese vaccine, I trust in that the most,” Orban said. “Some people think about vaccines ideologically, and they need a western one and not an eastern one. I think the Chinese have known this virus for the longest, and they probably know it the best.”

他說：“我在等待中國疫苗，也最相信中國疫苗。有人以意識形態(tài)思維認為應(yīng)該用西方而不是東方的疫苗。我認為中國人是最早認識這個病毒的，他們也最了解這個病毒?！?/p>

ideologically [?a?di??l?d??kli]：adv.思想上；意識形態(tài)上

Hungarian officials have criticised the EU for what they see as a slow vaccine roll-out, and in recent months have insisted that procuring vaccines developed in both western and eastern countries, such as Russia and China, would ensure that Hungarians get quick access to vaccinations.

匈牙利官員批評歐盟在疫苗采購和分配問題上動作緩慢，并在近幾個月堅稱，采購俄羅斯和中國等國家研發(fā)的疫苗，不管是來自西方還是東方，這將確保匈牙利人能迅速接種疫苗。

The announcement came a day after Hungary’s government issued a decree calling for a green light for any vaccine that had been administered to at least 1 million people in at least three other countries.

匈牙利政府在1月28日公布了一項法令，將對已經(jīng)在至少3個其他國家接種百萬以上人口的任何疫苗啟動批準程序。

Millions of doses made by Sinopharm and Sinovac shipped around the world to developing countries, particularly in Asia and Latin America.

數(shù)百萬劑中國國藥集團和中國科興生產(chǎn)的新冠疫苗被運往世界各地的發(fā)展中國家，尤其是在亞洲和拉丁美洲。

Meanwhile, EU countries, relying so far almost entirely on a vaccine from Pfizer, have fallen far behind Britain, the United States and a number of developing countries in rolling out vaccines.

與此同時，到目前為止幾乎完全依賴輝瑞疫苗的歐盟國家，在疫苗接種方面已經(jīng)遠遠落后于英國、美國和一些發(fā)展中國家。

Hungary’s drug regulator gave emergency use approval to the Sinopharm vaccine, rather than wait for the bloc’s European Medicines Agency (EMA) to give the go-ahead, adding it to a list that also includes the Pfizer, Moderna and AstraZeneca vaccines as well as Russia’s Sputnik-V shot.

匈牙利藥品監(jiān)管機構(gòu)并未等待歐洲藥品管理局(EMA)的批準，而是批準緊急使用中國國藥集團研發(fā)的新冠疫苗，并將其與輝瑞、摩德納、阿斯利康以及俄羅斯“衛(wèi)星V”等新冠疫苗一同列入緊急使用名單。

go-ahead[?ɡ?? ?hed]：n.批準，許可；放行信號

Premier Orban said the government monitored inoculations using the Chinese vaccine in neighbouring Serbia.

總理歐爾班說，匈牙利政府正密切關(guān)注鄰國塞爾維亞接種中國疫苗的情況。

Asked whether it had completed its study before authorising the vaccine, the drug regulator OGYEI said it gave the green light because the shot fit the conditions in the government decree. It said it would continue to keep track of the vaccine.

當被問及在批準該疫苗之前是否完成了相關(guān)研究時，匈牙利藥品監(jiān)管機構(gòu)OGYEI表示，之所以批準接種，是因為該疫苗符合政府法令。該機構(gòu)表示將繼續(xù)跟蹤疫苗接種情況。

It said that another state organisation, the National Public Health Centre, would put each vaccine shipment through tests, adding that 16 million people worldwide had already received the Sinopharm jab safely.

該機構(gòu)表示，另一個國家機構(gòu)國家公共衛(wèi)生中心將對每批疫苗進行檢測，并補充稱，全球已有1600萬人安全地接種了國藥集團的疫苗。

In Hungary, which has close to 10 million people, 364,909 people have been infected and 12,374 people have died of COVID-19 so far. The government has extended restrictions until March 1, including an 8 pm curfew and the closure of restaurants.

匈牙利總?cè)丝诮?000萬，新冠肺炎確診病例達364909例，死亡病例12374例。政府將疫情封鎖措施延長至3月1日，包括晚上8點后實行宵禁和關(guān)閉餐館。

英文來源：路透社

翻譯&編輯：yaning